The company expired its plan on October 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.41 CNY | +1.24% | -3.13% | -19.98% |
Mar. 01 | BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38% | MT |
Feb. 29 | BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.98% | 2.01B | |
-14.54% | 11.48B | |
+45.14% | 3.3B | |
-39.41% | 1.99B | |
-31.44% | 1.42B | |
+18.02% | 1.02B | |
-8.30% | 699M | |
-31.00% | 429M | |
-50.20% | 354M | |
-11.23% | 259M |
- Stock Market
- Equities
- 300676 Stock
- News BGI Genomics Co., Ltd.
- BGI Genomics Co., Ltd.'s Equity Buyback announced on October 27, 2021, has expired.